References
Myeloma - Cancer Stat Facts. SEER. https://seer.cancer.gov/statfacts/html/mulmy.html. Accessed 7 Aug 2020.
Ageing Europe—2019 edition. https://ec.europa.eu/eurostat/web/products-statistical-books/-/KS-02-19-681. Accessed 7 Aug 2020.
Population Projections. https://www.census.gov/programs-surveys/popproj.html. Accessed 7 Aug 2020.
Home—Office for National Statistics. https://www.ons.gov.uk/. Accessed 7 Aug 2020.
Mouhieddine TH, Sperling AS, Redd R, Park J, Leventhal M, Gibson CJ, et al. Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant. Nat Commun. 2020;11:2996.
Rustad EH, Yellapantula V, Leongamornlert D, Bolli N, Ledergor G, Nadeu F, et al. Timing the initiation of multiple myeloma. Nat Commun. 2020;11:1917.
Acknowledgements
We thank all the patients and their families for their contributions to this study. The authors acknowledge continued support from Multiple Myeloma Research Foundation and the Perelman Family Foundation. BAW and GJM received grant support through a Translational Research Program award from the Leukemia & Lymphoma Society (6020-20). EMB received funding from the Fédération Française de Recherche sur le Myélome et les Gammapathies under the aegis of the Fondation de France.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Boyle, E.M., Williams, L., Blaney, P. et al. Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length. Leukemia 36, 221–224 (2022). https://doi.org/10.1038/s41375-021-01320-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-021-01320-3
- Springer Nature Limited
This article is cited by
-
Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL
Leukemia (2022)
-
Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patients
Leukemia (2022)
-
Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms
Blood Cancer Journal (2022)
-
Mortality trends in multiple myeloma after the introduction of novel therapies in the United States
Leukemia (2022)